Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5867 Articles

Chris Lange | Jan 3, 2020 at 11:15 AM EST

The Top Biotech ETFs to Watch in 2020

On a company by company basis, investing in biotechs is somewhat tricky. However, there is an investment strategy that makes…

Jon C. Ogg | Jan 2, 2020 at 4:51 PM EST

Is Pfizer Raising Drug Prices Too Much in 2020?

Ahead of election years, the cost and future of health care has become one of the top debates for better…

Chris Lange | Jan 2, 2020 at 10:25 AM EST

The Top Biopharma Events to Watch in 2020

Here, 24/7 Wall St. presents a calendar of a few of the biggest clinical trial and FDA updates to watch…

Chris Lange | Jan 2, 2020 at 9:55 AM EST

Why This Hairy Cell Leukemia Treatment Could Be Big in Europe

Innate Pharma shares jumped on Thursday after the firm announced that the European Medicines Agency has accepted the Marketing Authorization…

$Why This Refractory Angina Treatment Could Be a Big Hit$

Chris Lange | Dec 31, 2019 at 10:10 AM EST

Why This Refractory Angina Treatment Could Be a Big Hit

Neovasc shares nearly doubled on Tuesday after the firm announced the submission of an application to the FDA for its…

Chris Lange | Dec 30, 2019 at 1:10 PM EST

Is It Over for This Huntington’s Disease Clinical Trial?

Wave Life Sciences shares dropped sharply to start out the week after the company announced topline data from its ongoing…

Chris Lange | Dec 30, 2019 at 12:30 PM EST

Why One Analyst Sees Sarepta’s Roche Deal Taking Off

Sarepta shares jumped last week on news that the company reached a licensing deal with Roche. While investors saw about…

Chris Lange | Dec 30, 2019 at 10:20 AM EST

Why This aPAP Treatment Is a Big Hit

Savara shares more than doubled on Monday after the firm announced that the FDA has granted Breakthrough Therapy designation for…

Chris Lange | Dec 30, 2019 at 9:50 AM EST

AstraZeneca’s FDA Nod Could Be Big

AstraZeneca has announced that the FDA has approved its companion diagnostic test that identifies patients with metastatic pancreatic cancer.

Chris Lange | Dec 27, 2019 at 1:00 PM EST

Why This Uriniary Tract Infection Trial Could Be Huge

Iterum Therapeutics shares more than doubled on Friday after the firm announced that it had completed the enrollment of its…

Chris Lange | Dec 27, 2019 at 8:50 AM EST

Why This Osteoarthritis Treatment Is Making Waves

Flexion Therapeutics shares popped on Friday after the company announced that the FDA has approved a supplemental New Drug Application…

Chris Lange | Dec 26, 2019 at 3:19 PM EST

The Top Healthy Living ETFs of 2019

Eating a nutritious and well-balanced diet, exercising regularly and abstaining from bad habits like smoking greatly increase one’s odds of…

Chris Lange | Dec 26, 2019 at 12:05 PM EST

Could This Breast Cancer Study Be the Next Big Thing?

Immunomedics shares made a handy gain on Thursday after the company announced that the FDA has accepted its Biologics License…

Chris Lange | Dec 26, 2019 at 10:00 AM EST

Why This Cancer Study Is Crushing Spectrum Pharma

Spectrum Pharma shares were halved on Thursday after the firm provided an update on its midstage cancer study some updates…

Paul Ausick | Dec 26, 2019 at 9:46 AM EST

A Third of Adolescents Make Risky Lifestyle Choices

A new analysis of data collected from more than 300,000 adolescents worldwide show that more than a third engage in…

1 … 73 74 75 76 77 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

The Top Biotech ETFs to Watch in 2020

Is Pfizer Raising Drug Prices Too Much in 2020?

The Top Biopharma Events to Watch in 2020

Why This Hairy Cell Leukemia Treatment Could Be Big in Europe

Why This Refractory Angina Treatment Could Be a Big Hit

Is It Over for This Huntington’s Disease Clinical Trial?

Why One Analyst Sees Sarepta’s Roche Deal Taking Off

Why This aPAP Treatment Is a Big Hit

AstraZeneca’s FDA Nod Could Be Big

Why This Uriniary Tract Infection Trial Could Be Huge

Why This Osteoarthritis Treatment Is Making Waves

The Top Healthy Living ETFs of 2019

Could This Breast Cancer Study Be the Next Big Thing?

Why This Cancer Study Is Crushing Spectrum Pharma

A Third of Adolescents Make Risky Lifestyle Choices

‘You Bought Stupid Cars You Can’t Afford. You Didn’t Buy a Stupid House.’: Dave Ramsey to Spokane Caller Sitting on $900K Inherited Home and $100K in Debt

This $575,000 Portfolio Pays More Cash Every Month Than $1 Million in the S&P 500

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

'You Bought Stupid Cars You Can't Afford. You Didn't Buy a Stupid House.': Dave Ramsey to Spokane Caller Sitting on $900K Inherited Home and $100K in Debt

This $575,000 Portfolio Pays More Cash Every Month Than $1 Million in the S&P 500

‘You Bought Stupid Cars You Can’t Afford. You Didn’t Buy a Stupid House.’: Dave Ramsey to Spokane Caller Sitting on $900K Inherited Home and $100K in Debt

This $575,000 Portfolio Pays More Cash Every Month Than $1 Million in the S&P 500

Health and Healthcare Articles

All Health and Healthcare Articles

The Top Biotech ETFs to Watch in 2020

Is Pfizer Raising Drug Prices Too Much in 2020?

The Top Biopharma Events to Watch in 2020

Why This Hairy Cell Leukemia Treatment Could Be Big in Europe

Why This Refractory Angina Treatment Could Be a Big Hit

Is It Over for This Huntington’s Disease Clinical Trial?

Why One Analyst Sees Sarepta’s Roche Deal Taking Off

Why This aPAP Treatment Is a Big Hit

AstraZeneca’s FDA Nod Could Be Big

Why This Uriniary Tract Infection Trial Could Be Huge

Why This Osteoarthritis Treatment Is Making Waves

The Top Healthy Living ETFs of 2019

Could This Breast Cancer Study Be the Next Big Thing?

Why This Cancer Study Is Crushing Spectrum Pharma

A Third of Adolescents Make Risky Lifestyle Choices

‘You Bought Stupid Cars You Can’t Afford. You Didn’t Buy a Stupid House.’: Dave Ramsey to Spokane Caller Sitting on $900K Inherited Home and $100K in Debt

This $575,000 Portfolio Pays More Cash Every Month Than $1 Million in the S&P 500

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

Featured Reads

'You Bought Stupid Cars You Can't Afford. You Didn't Buy a Stupid House.': Dave Ramsey to Spokane Caller Sitting on $900K Inherited Home and $100K in Debt

This $575,000 Portfolio Pays More Cash Every Month Than $1 Million in the S&P 500